How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy
Adam Fundytus, Christopher M. Booth, Ian F. Tannock
Topics & Concepts
MedicineImmunotherapyBiomarkerCancerOncologyCancer immunotherapyInternal medicineCancer researchChemistryBiochemistryCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCancer Cells and Metastasis